drugset / Trial / NCT00892957

FS VH S/D 500 S-apr in Vascular Surgery

NCT00892957 ↗

Phase 3 Completed 176 enrolled Baxter Healthcare Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study was to compare safety and efficacy of FS VH S/D 500 s-apr (FS) versus manual compression in prosthetic expanded polytetrafluoroethylene (ePTFE) graft placement.

Timeline

Start
2009-07
Primary completion
2010-10
Completion
2010-11

Outcome

Met primary endpoint

registry p <0.0001; Likelihood ratio chi-square test NCT00892957 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject FS VH S/D 500 s-apr Protein / enzyme biologic — —

Indications

No indication recorded.